Thermo Fisher launches Gibco Bacto CD Supreme media to streamline E. coli-based plasmid DNA and recombinant protein manufacturing for gene and mRNA therapies.
Vaibhavi M.
Hikma names Said Darwazah as CEO after Riad Mishlawi steps down, reaffirming its 2025 financial guidance.
Vaibhavi M.
FDA approves Enhertu plus pertuzumab as a first-line treatment for HER2-positive metastatic breast cancer, showing significant progression-free survival benefits.
Vaibhavi M.
Adaptive partners with Pfizer on TCR discovery and immune data licensing to accelerate autoimmune and drug research.
Simantini Singh Deo